Search Results

Filter
  • 1-10 of  2,111 results for ""Cysteamine""
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Comparative Analysis of Cystamine and Cysteamine as Radioprotectors and Antioxidants: Insights from Monte Carlo Chemical Modeling under High Linear Energy Transfer Radiation and High Dose Rates.

  • Authors : Penabeï S; Department of Medical Imaging and Radiation Sciences, Faculty of Medicine and Health Sciences, Université de Sherbrooke, 3001, 12th Avenue Nord, Sherbrooke, QC J1H 5N4, Canada.; Meesungnoen J

Subjects: Cystamine*/Cystamine*/Cystamine*/chemistry ; Cystamine*/Cystamine*/Cystamine*/pharmacology ; Cysteamine*/Cysteamine*/Cysteamine*/chemistry

  • Source: International journal of molecular sciences [Int J Mol Sci] 2024 Sep 29; Vol. 25 (19). Date of Electronic Publication: 2024 Sep 29.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101092791 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Response to Cysteamine in Osteoclasts Obtained from Patients with Nephropathic Cystinosis: A Genotype/Phenotype Correlation.

  • Authors : Quinaux T; Centre de Référence des Maladies Rénales Rares, Centre de Référence des Maladies Rares du Calcium et du Phosphore, Filières de Santé Maladies Rares OSCAR, ORKID et ERK-Net, Hôpital Femme Mère Enfant, 69500 Bron, France.; INSERM 1033 Research Unit, 69008 Lyon, France.

Subjects: Cysteamine/Cysteamine/Cysteamine/*pharmacology ; Cystinosis/Cystinosis/Cystinosis/*genetics ; Osteoclasts/Osteoclasts/Osteoclasts/*metabolism

  • Source: Cells [Cells] 2021 Sep 21; Vol. 10 (9). Date of Electronic Publication: 2021 Sep 21.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Cysteamine with In Vitro Antiviral Activity and Immunomodulatory Effects Has the Potential to Be a Repurposing Drug Candidate for COVID-19 Therapy.

  • Authors : Alonzi T; Translational Research Unit, National Institute for Infectious Diseases 'Lazzaro Spallanzani'-IRCCS, 00149 Rome, Italy.; Aiello A

Subjects: COVID-19 Drug Treatment*; Antiviral Agents/Antiviral Agents/Antiviral Agents/*pharmacology ; Cysteamine/Cysteamine/Cysteamine/*pharmacology

  • Source: Cells [Cells] 2021 Dec 24; Vol. 11 (1). Date of Electronic Publication: 2021 Dec 24.Publisher: MDPI Country of Publication: Switzerland NLM ID: 101600052 Publication Model: Electronic Cited Medium:

Record details

×
Academic Journal

Clinical Efficacy of Cysteamine Application for Melasma: A Meta-Analysis.

  • Source: Journal of Clinical Medicine; Dec2024, Vol. 13 Issue 23, p7483, 15p

Record details

×
Academic Journal

PEP-1-GLRX1 Reduces Dopaminergic Neuronal Cell Loss by Modulating MAPK and Apoptosis Signaling in Parkinson's Disease.

  • Authors : Choi YJ; Department of Biomedical Science and Research Institute of Bioscience and Biotechnology, Hallym University, Chuncheon 24252, Korea.; Kim DW

Subjects: Cysteamine/Cysteamine/Cysteamine/*analogs & derivatives ; Dopaminergic Neurons/Dopaminergic Neurons/Dopaminergic Neurons/*cytology ; Glutaredoxins/Glutaredoxins/Glutaredoxins/*administration & dosage

  • Source: Molecules (Basel, Switzerland) [Molecules] 2021 Jun 01; Vol. 26 (11). Date of Electronic Publication: 2021 Jun 01.Publisher: MDPI Country of Publication: Switzerland NLM ID: 100964009 Publication Model: Electronic Cited Medium:

Record details

×
  • 1-10 of  2,111 results for ""Cysteamine""